Preoperative concurrent paclitaxel, carboplatin and radiotherapy in advanced operable cancer of the oropharynx and oral cavity: A phase II evaluation

被引：0
|
作者：
Eckhardt, A
Wildfang, I
Karstens, JH
机构：
[1] Hannover Med Univ, Dept Oral & Maxillofacial Surg, Hannover, Germany
[2] Hannover Med Univ, Dept Radiat Oncol, Hannover, Germany
来源：
EUROPEAN JOURNAL OF CANCER | 1999年 / 35卷
关键词：
D O I：
10.1016/S0959-8049(99)81088-0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
660
引用
收藏
页码：S174 / S174
页数：1
相关论文
共 50 条
  • [21] Phase II trial of preoperative capecitabine with concurrent radiotherapy in patients with locally advanced rectal cancer
    De Las Heras, M.
    Arias, F.
    Del Moral, R.
    Gomez-Millán, J.
    Jiménez, E.
    Wals, A.
    Alcántara, P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : S305 - S305
  • [22] Paclitaxel and carboplatin in pretreated advanced gastric cancer: A phase II study
    Stathopoulos, GP
    Rigatos, SK
    Fountzilas, G
    Polyzos, A
    Stathopoulos, JG
    ONCOLOGY REPORTS, 2002, 9 (01) : 89 - 92
  • [23] Phase II study of paclitaxel and carboplatin in patients with advanced gastric cancer
    Gadgeel, SM
    Shields, AF
    Heilbrun, LK
    Labadidi, S
    Zalupski, M
    Chaplen, R
    Philip, PA
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2003, 26 (01): : 37 - 41
  • [24] Preoperative chemotherapy for esophageal cancer with paclitaxel and carboplatin: Results of a phase II trial
    Keresztes, RS
    Port, JL
    Pasmantier, MW
    Korst, RJ
    Altorki, NK
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2003, 126 (05): : 1603 - 1608
  • [25] Adjuvant carboplatin and paclitaxel after concurrent cisplatin and radiotherapy in patients with locally advanced cervical cancer
    Yavas, Guler
    Yavas, Cagdas
    Sen, Erdem
    Oner, Irem
    Celik, Cetin
    Ata, Ozlem
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 (01) : 42 - 47
  • [26] A Phase II Preoperative Trial of Concurrent Trastuzumab and Paclitaxel without Anthracycline in HER2-Positive Operable Breast Cancer
    Sato, T.
    Hayashida, T.
    Takahashi, M.
    Sakata, M.
    Jinno, H.
    Hirose, S.
    Mukai, M.
    Kitagawa, Y.
    CANCER RESEARCH, 2010, 70
  • [27] Phase II, randomized trial of preoperative epirubicin-paclitaxel +/- gefitinib with biomarker evaluation in operable breast cancer
    Guarneri, Valentina
    Frassoldati, Antonio
    Ficarra, Guido
    Puglisi, Fabio
    Andreetta, Claudia
    Michelotti, Andrea
    Cresti, Nicola
    Boni, Corrado
    Bisagni, Giancarlo
    Berardi, Rossana
    Battelli, Nicola
    Santoro, Armando
    Banna, Giuseppe
    Bottini, Alberto
    Di Blasio, Beatrice
    Maiorana, Antonino
    Piacentini, Federico
    Giovannelli, Simona
    Jovic, Gordana
    Conte, PierFranco
    BREAST CANCER RESEARCH AND TREATMENT, 2008, 110 (01) : 127 - 134
  • [28] Phase II, randomized trial of preoperative epirubicin-paclitaxel +/− gefitinib with biomarker evaluation in operable breast cancer
    Valentina Guarneri
    Antonio Frassoldati
    Guido Ficarra
    Fabio Puglisi
    Claudia Andreetta
    Andrea Michelotti
    Nicola Cresti
    Corrado Boni
    Giancarlo Bisagni
    Rossana Berardi
    Nicola Battelli
    Armando Santoro
    Giuseppe Banna
    Alberto Bottini
    Beatrice Di Blasio
    Antonino Maiorana
    Federico Piacentini
    Simona Giovannelli
    Gordana Jovic
    PierFranco Conte
    Breast Cancer Research and Treatment, 2008, 110 : 127 - 134
  • [29] Radiotherapy concurrent with weekly docetaxel for advanced cancer of oropharynx and hypopharynx
    Fukada, J.
    Shigematsu, N.
    Tomita, T.
    Kubo, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S455 - S456
  • [30] Organ and function preserving treatment for locoregionally advanced squamous cell carcinoma of the oral cavity and the oropharynx: Superselective intra-arterial carboplatin infusion with concurrent radiotherapy
    Oya, R
    Ikemura, K
    ORAL ONCOLOGY, VOL V, 1997, : 225 - 228
12345